Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine
- PMID: 37651090
- PMCID: PMC10519926
- DOI: 10.1007/s13770-023-00560-x
Biotherapeutic Applications of Platelet-Rich Plasma in Regenerative Medicine
Abstract
Background: Platelet-rich plasma (PRP), a blood-based product containing platelets and growth factors, is being utilized to treat numerous non-hemostatic disorders. Studies have explored the use of PRP to provide rapid repair, healing, and recovery from various injuries; some studies mentioned the effectiveness of PRP as compared with other forms of treatment like the use of hyaluronic acid. Commercially available PRP systems are available now, and each varies from one another depending on how it is prepared, thus causing variations in platelet concentration and growth factor content. These variations also implicated different therapeutic applications.
Methods: The paper reviews the various applications of PRP, including factors to consider before using PRP therapy, and provides an extensive list of PRP applications.
Results: The administration of PRP as a standalone treatment or as a co-therapy results in observed positive outcomes. However, there is a lack of standardization for PRP preparation, increasing the risks for heterogeneity and bias amongst results.
Conclusion: The use of PRP is indeed an option for regenerative therapy, but more research is needed before it can fully be recommended as a primary treatment modality.
Keywords: Biotherapy; Platelet; Platelet-rich plasma; Regenerative medicine; Treatment.
© 2023. Korean Tissue Engineering and Regenerative Medicine Society.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ren M, Zhong X, Ma CY, et al. Insulin-like growth factor-1 promotes cell cycle progression via upregulation of cyclin D1 expression through the phosphatidylinositol 3-kinase/nuclear factor-kB signaling pathway in FRTL thyroid cells. Acta Pharmacol Sin. 2009;30:113–119. doi: 10.1038/aps.2008.8. - DOI - PubMed
-
- Gan QF, Choy KW, Foo CN, Leong PP, Cheong SK. Incorporating insulin growth Factor-1 into regenerative and personalised medicine for musculoskeletal disorders: a systematic review. J Tissue Eng Regen Med. 2021;15:419–441. doi: 10.1002/term.3192. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials